The saga of XMRV: a virus that infects human cells but is not a human virus.

Emerg Microbes Infect

Cancer Research Institute and Department of Molecular Biology and Biochemistry, University of California, Irvine, CA 92697-3905, USA.

Published: April 2014

Xenotropic murine leukemia virus-related virus (XMRV) was discovered in 2006 in a search for a viral etiology of human prostate cancer (PC). Substantial interest in XMRV as a potentially new pathogenic human retrovirus was driven by reports that XMRV could be detected in a significant percentage of PC samples, and also in tissues from patients with chronic fatigue syndrome (CFS). After considerable controversy, etiologic links between XMRV and these two diseases were disproven. XMRV was determined to have arisen during passage of a human PC tumor in immunocompromised nude mice, by activation and recombination between two endogenous murine leukemia viruses from cells of the mouse. The resulting XMRV had a xentropic host range, which allowed it replicate in the human tumor cells in the xenograft. This review describes the discovery of XMRV, and the molecular and virological events leading to its formation, XMRV infection in animal models and biological effects on infected cells. Lessons from XMRV for other searches of viral etiologies of cancer are discussed, as well as cautions for researchers working on human tumors or cell lines that have been passed through nude mice, includingpotential biohazards associated with XMRV or other similar xenotropic murine leukemia viruses (MLVs).

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008767PMC
http://dx.doi.org/10.1038/emi.2014.25DOI Listing

Publication Analysis

Top Keywords

murine leukemia
12
xmrv
10
xenotropic murine
8
human tumor
8
nude mice
8
leukemia viruses
8
human
7
saga xmrv
4
xmrv virus
4
virus infects
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!